Dr. Andrew Sloan
Claim this profileUniversity Hospitals Cleveland Medical Center
Studies Glioblastoma
Studies Brain Cancer
4 reported clinical trials
12 drugs studied
Area of expertise
1Glioblastoma
IDH negative
MGMT negative
Stage III
2Brain Cancer
IDH negative
MGMT negative
Affiliated Hospitals
Clinical Trials Andrew Sloan is currently running
LITT + Pembrolizumab
for Glioblastoma
The purpose of this study is to test the side effects and efficacy of using Laser Interstitial Thermotherapy (LITT) combined with Pembrolizumab. LITT is a minimally invasive surgical technique that uses a laser to heat brain tumors. Pembrolizumab is an investigational (experimental) drug that works by helping participants' immune system work correctly to detect and fight cancer cells. Pembrolizumab is experimental because it is not approved by the Food and Drug Administration (FDA), for this use, though it is approved to treat other cancers.
Recruiting1 award Phase 1 & 2
Stem Cell Rescue Therapy
for Glioblastoma
This phase II trial studies the effect of P140K MGMT hematopoietic stem cells, O6-benzylguanine, temozolomide, and carmustine in treating participants with supratentorial glioblastoma or gliosarcoma who have recently had surgery to remove most or all of the brain tumor (resected). Chemotherapy drugs, such as 6-benzylguanine, temozolomide, and carmustine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing. Placing P140K MGMT, a gene that has been created in the laboratory into bone marrow making the bone more resistant to chemotherapy, allowing intra-patient dose escalation which kills more tumor cells while allowing bone marrow to survive.
Recruiting1 award Phase 2
More about Andrew Sloan
Clinical Trial Related7 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Andrew Sloan has experience with
- Temozolomide
- Laser Interstitial Thermotherapy
- Pembrolizumab
- Carmustine
- Filgrastim
- O6-benzylguanine
Breakdown of trials Andrew Sloan has run
Glioblastoma
Brain Cancer
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Sloan specialize in?
Andrew Sloan focuses on Glioblastoma and Brain Cancer. In particular, much of their work with Glioblastoma has involved IDH negative patients, or patients who are MGMT negative.
Is Andrew Sloan currently recruiting for clinical trials?
Yes, Andrew Sloan is currently recruiting for 2 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Andrew Sloan has studied deeply?
Yes, Andrew Sloan has studied treatments such as Temozolomide, Laser Interstitial Thermotherapy, Pembrolizumab.
What is the best way to schedule an appointment with Andrew Sloan?
Apply for one of the trials that Andrew Sloan is conducting.
What is the office address of Andrew Sloan?
The office of Andrew Sloan is located at: University Hospitals Cleveland Medical Center, Cleveland, Ohio 44106 United States. This is the address for their practice at the University Hospitals Cleveland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.